Tobacco reg use of FDA resources questioned; House Oversight Subcommittee search for "smoking gun"?.
FDA TOBACCO REGULATION: RESOURCE ALLOCATION QUESTIONS RAISED by former FDA Special Assistant for Investigations James Phillips in a recent letter to the House Commerce Committee. Phillips joined FDA in 1991 from Sen. Hatch's (R-Utah) staff, to which he returned after leaving the agency in July 1994. He is currently on the staff of Rep. Bachus' (R-Ala.) Banking/General Oversight & Investigations Subcommittee. During Hatch's tenure on the Labor & Human Resources Committee, Phillips served as chief minority investigator and director of oversight and investigations.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth